Advances in the acute pharmacologic management of cardiac arrhythmias

Current Cardiology Reports

Volumn 5, Issue 5, 2003, Pages 387-394

  Sarkozy, Andrea ^a   Dorian, Paul ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; ISOPRENALINE; LIDOCAINE; MAGNESIUM; METOPROLOL; PLACEBO; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL;

ACUTE DISEASE; ACUTE HEART INFARCTION; BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART HEMODYNAMICS; HEART PACING; HEART PROARRHYTHMIA; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; MEDICAL DECISION MAKING; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; QRS COMPLEX; QT INTERVAL; REENTRY TACHYCARDIA; REVIEW; RISK ASSESSMENT; SHOCK; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS; CLASSIFICATION; DISEASE MANAGEMENT; PATHOPHYSIOLOGY; TIME;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DISEASE MANAGEMENT; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HUMANS; TIME FACTORS;

EID: 0642315355     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0096-y     Document Type: Review

References (50)

1. Fuster V, Ryden LE, Asinger RW, et al.: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001, 104:2118-2150.
2. Atkins DL, Dorian P, Gonzalez ER, et al.: Treatment of tachyarrhythmias. Ann Emerg Med 2001, 37:S91-S109.
3. Falk RH: Ventricular rate control in the elderly: is digoxin enough? Am J Geriatr Cardiol 2002, 11:353-356.
4. Karth GD, Geppert A, Neunteuff T, et al.: Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001, 29:1149-1153.
5. Danias PG, Caulfield TA, Weigner MJ, et al.: Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998, 313:588-592.
6. Reimold SC, Maisel HM, Antman EM: Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis. Am J Cardiol 1998, 82:66N-71N.
7. Boriani G, Martignani C, Biffi M, et al.: Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment. Drugs 2002, 62:415-423.
8. Alp NJ, Bell JA, Shahi M: Randomised, double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart 2000, 84:37-40.
9. Khan IA: Oral loading single dose flecainide for pharmacological cardioversion of recent onset atrial fibrillation. Chest 2002, 122:180S.
10. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio AO, et al.: Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 2000, 86:950-953.
11. Khan IA, Mehta NJ, Gowda RM: Amiodarone for pharmacological cardioversion of recent onset atrial fibrillation. Chest 2002, 122:181S.
12. Hilleman DE, Spinler SA: Conversion of recent onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. Pharmacotherapy 2002, 22:66-74.
13. Chevalier P, Durand-Dubief A, Burri H, et al.: Amiodarone versus placebo and class I/c drugs for cardioversion of recent onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003, 41:255-262.
14. Naccarelli GV, Lee KS, Gibson JK, et al.: Electrophysiology and pharmacology of ibutilide. Am J Cardiol 1996, 78:12-16.
15. Abi-Mansour P, Carberry PA, McCowan RJ, et al.: Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Am Heart J 1998, 136:632-642.
16. Stambler BS, Wood MA, Ellenbogen KA, et al.: Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 1996, 94:1613-1621.
17. Howard PA: Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter. Ann Pharmacother 1999, 33:38-47.
18. Oral H, Souza JJ, Michaud GF, et al.: Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999, 340:1849-1854.
19. Glatter K, Yang Y, Chatterjee K, et al.: Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation 2001, 103:253-257.
20. Mounsey JP, DiMarco JP: Cardiovascular drugs. Dofetilide. Circulation 2000, 102:2665-2670.
21. Falk RH, Pollak A, Singh SN, et al.: intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol 1997, 29:385-390.
22. Norgaard BL, Wachtell K, Christensen PD, et al.: Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. Am Heart J 1999, 137:1062-1069.
23. Lindeboom JE, Kingma JH, Crijns HJ, et al.: Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and flutter. Am J Cardiol 2000, 85:1031-1033.
24. Bianconi L, Castro A, Dinelli M, et al.: Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. Eur Heart J 2000, 21:1265-1273.
25. Greenbaum RA, Campbell TJ, Channer KS, et al.: Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) study. Circulation 1998, 98(Suppl):1-633.
26. Singh S, Zoble RG, Yellen L, et al.: Efficacy and safety of oral dofetilide in maintaining sinus rhythm in patients with chronic atrial fibrillation/flutter (SAFIRE-D) Study. Circulation 2000, 102:2385-2390.
27. Ferguson JD, DiMarco JP: Contemporary management of paroxysmal supraventricular tachycardia. Circulation 2003, 107:1096-1099.
28. Wellens HJ: Ventricular tachycardia: diagnosis of broad complex tachycardia. Heart 2001, 86:579-585.
29. Dorian P, Cass D: An overview of the management of electrical storm. Can J Cardiol 1997, 13(Suppl A): 13A-17A.
30. Nasir N, Jr., Taylor A, Doyle TK et al.: Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction. Am J Cardiol 1994, 74:1183-1186.
31. Armengol RE, Graff J, Baerman JM, et al.: Lack of effectiveness of lidocaine for sustained, wide QRS complex tachycardia. Ann Emerg Med 1989, 18:254-257.
32. Gorgels AP, van den Dool A, Hofs A, et al.: Comparison of procainamide and lidocaine in terminating sustained monomoprhic ventricular tachycardia. Am J Cardiol 1996, 78:43-46.
33. Callans DJ, Marchlinski FE: Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. J Am Coll Cardiol 1992, 19:111-117.
34. Scheinman MM, Levine JH, Cannom DS, et al.: Dose-ranging study of intravenous amiodarone in patients with life threatening ventricular tachyarrhythmias. Circulation 1995, 92:3263-3272.
35. Kowey PR, Levine JH, Herre JM, et al.: Randomized double blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation 1995, 92:3255-3263.
36. Levine JH, Massumi A, Scheinman MM, et al.: Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996, 27:67-75.
37. Nademanee K, Taylor R, Bailey WE, et al.: Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000, 102:742-747.
38. Dorian P, Philippon F: The management of acute ventricular tachycardia or fibrillation. Can J Cardiol 2000, 16(Suppl C):16C-19C.
39. Kowey PR, Bharucha DB, Rials SJ, et al.: Intravenous antiarrhythmic therapy for high-risk patients. Eur Heart J 1999, 1(Suppl C):C36-C40.
40. White RD, Russell JK: Refibrillation, resuscitation and survival in out-of-hospital sudden cardiac arrest victims treated with biphasic automated external defibrillators. Resuscitation 2002, 55:17-23.
41. Kudenchuk PJ, Cobb LA, Copass MK, et al.: Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999, 341:871-878.
42. Dorian P, Cass D, Schwartz B, et al.: Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002, 346:884-890.
43. Nolan JP, Latorre FJ, Steen PA, et al.: Advanced life support drugs: do they really work? Curr Opin Crit Care 2002, 8:212-218.
44. Kudenchuk PJ: Advanced cardiac life support antiarrhythmic drugs. Cardiol Clin 2002, 20:79-87.
45. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care International consensus on science. Circulation 2000, 102:(Suppl):190-193.
46. MacMahon S, Collins R, Peto R, et al.: Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1988, 260:1910-1916.
47. Hine LK, Laird N, Hewitt P, et al.: Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989, 149:2694-2698.
48. Weaver WD, Fahrenbruch DCE, Johnson DD, et al.: Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990, 82:2027-2034.
49. Allegra J, Lavery R, Cody R, et al.: Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 2001, 49:245-249.
50. Hassan TB, Jagger C, Barnett DB: A randomized trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J 2002, 19:57-62.